ZERONDA TYLER (Interim CFO) received a stock award from VYNE THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2024ACC: 0001209191-24-000470
Officer· Interim CFO
Since Jun 2021
+124.91K
Net shares
Net buyer
$212.04
Total sold
0
Open market trades
0B · 0S
3
Total transactions
125K acquired · 93.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+62.50K
Price / share
—
Trade value
—
% of position
90.0%
1/1/2024
69.43K→131.93K
Common Stock
Direct
Shares
−93.00
Price / share
$2.28
Trade value
$212.04
% of position
0.1%
1/2/2024
131.93K→131.84K
Total
Net shares
+62.41K
Net value
-$212.04
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2024 | A · Award | +62.50K | — | — | 90.0% | 69.43K | 131.93K |
| Common Stock Direct | 1/2/2024 | F · Tax Withholding | −93.00 | $2.28 | $212.04 | 0.1% | 131.93K | 131.84K |
| Total | +62.41K | -$212.04 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
62.50K shares
Shares
+62.50K
Strike price
2.33
Held after
62.50K
Exercisable
—
1/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock62.50K shares | 1/1/2024 | A · Award | +62.50K | 2.33 | — | 62.50K |